X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

July 10, 2020

Mitigating Risk in Pharmaceutical Manufacturing with Visually-Inspected Components

<p><span>The overall quality of a final drug product depends on the components of its packaging and delivery systems.&nbsp; The use of visually inspected components reduces the risk of defective components and helps ensure patient safety.</span></p>
Olga Laskina

Olga Laskina, Ph.D.

Sr. Technical Account Specialist, NA

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    Plungers Vision Inspection

    June 26, 2018

    Inspecting Elastomer Components: Can You Spot a Defect?

    Bill Matakas

    Bill Matakas

    Sr. Director, Product Management & Marketing Operations

    elastomer component defect rate on finished drug product

    October 19, 2015

    Looking for Ways to Reduce End of Line Rejects Significantly

    West Pharma

    Bjoern Henze, Ph.D.

    Manager, Technical Customer Support, Commercial